PharVision Advisers’s Walker & Dunlop WD Stock Holding History

PharVision Advisers’s Portfolio WD Stock Details WD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,962	Closed	-$209K	–	806
2025 Q2	$209K	Buy	+2,962	New	+$214K	0.3%	189

Other funds holding WD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's WD Position: Q3 2025 in Review

PharVision Advisers sold out of Walker & Dunlop (WD) in Q3 2025, closing a stake of 2,962 shares — an estimated $209K sold.

PharVision Advisers first reported a position in WD in Q2 2025 and held it in 1 quarter. The position peaked at $209K in Q2 2025. 283 funds tracked by Wall St. Rank hold WD as of Q3 2025.

PharVision Advisers reported no remaining Walker & Dunlop position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 2,962 Walker & Dunlop shares in Q3 2025, an estimated $209K.
PharVision Advisers first reported a position in Walker & Dunlop in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Walker & Dunlop position peaked at $209K in Q2 2025.
283 funds tracked by Wall St. Rank held Walker & Dunlop as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.